Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSymphony Env. Regulatory News (SYM)

Share Price Information for Symphony Env. (SYM)

Share Price is delayed by 15 minutes
Get Live Data
8.25    0.00 (0.00%)
Bid:
7.50
Ask:
9.00
Spread: 1.50 (20.00%)
Market Cap: £19.50m
SYM Live PriceLast checked at - London Stock Exchange

Intraday Symphony Env. Share Chart

EPA Ireland update

19 Sep 2025 16:55

RNS Number : 1240A
Symphony Environmental Tech. PLC
19 September 2025
 

 

19 September 2025

SYMPHONY ENVIRONMENTAL TECHNOLOGIES PLC

("Symphony", the "Company" or the "Group")

EPA Ireland Update

 

 

Symphony Environmental Technologies Plc (AIM:SYM), global specialists in technologies that make plastic and rubber products "smarter, safer and sustainable," is making this further update.

 

On 8th July 2025 Symphony announced that it had received confirmation from the Environmental Protection Agency of Ireland ("EPA") as follows:

 

"We can confirm that d2w products do not fall within the scope of the Single-use Plastics Directive (EU) 2019/904, which prohibits the use of certain plastic materials due to their contribution to microplastic pollution. The d2w technology has been scientifically demonstrated to undergo full biodegradation without leaving behind persistent microplastics or toxic residues. This conclusion is supported by independent studies and aligns with the objectives of the Directive to reduce plastic pollution and promote sustainable alternatives."

 

Furthermore, the EPA said "we have reviewed the Commission Notice (2021/C 216/01) published in the Official Journal of the European Union on 7 June 2021, which provides Guidelines on the implementation of the Directive. Based on the evidence submitted, we are satisfied that d2w products are not subject to the restrictions outlined in the Directive or its accompanying Guidelines."

 

Symphony has now been informed by the EPA that it has no function to issue an assurance that a product is outside the scope of Article 5 of Directive (EU) 2019/904, and Symphony has received an apology. In Symphony's view it follows that the EPA has no function to decide whether a product is within the scope of Article 5, but officials in the EPA consider that they should follow the Guidelines, which in their view bring d2w plastic products within the scope of Article 5.

 

The EPA has however accepted that these Guidelines are not legally binding and has not disputed that they were written without the benefit of subsequent scientific evidence. It has also accepted that the General Court of the EU (in the case brought by Symphony against the EU Institutions) "did not make a determination as to whether the [d2w] Product is oxo-degradable plastic or not."

 

For the following reasons Symphony considers that the Guidelines are demonstrably incorrect: Recital 15 says "this Directive should cover products made from oxo-degradable plastic, as that type of plastic does not properly biodegrade and thus contributes to microplastic pollution in the environment." It follows therefore that plastics that have been scientifically demonstrated to undergo full biodegradation without leaving persistent microplastics or toxic residues are not oxo-degradable plastic for the purposes of the Directive.

 

The EPA has not changed its earlier position that "d2w technology has been scientifically demonstrated to undergo full biodegradation without leaving behind persistent microplastics or toxic residues."

 

As to Art.3(3) of the Directive, the EPA has not disputed the scientific evidence produced to it that (a) the d2w masterbatch does not "lead to" anything - as the process of oxidation would occur anyway, and even if it did (b) the plastic does not fragment into microplastics, and (c) there is no chemical decomposition. 

 

Symphony has been advised by Mr. Josh Holmes KC that the Directive can and should be interpreted so as to allow products made with d2w technology to be placed on the market in the EU.

 

 

 

Enquiries:

Symphony Environmental Technologies Plc

Michael Laurier, CEO

Tel: +44 (0) 20 8207 5900

Ian Bristow, CFO

www.symphonyenvironmental.com

Zeus (Nominated Adviser and Broker)

David Foreman, Emma Burn (Investment Banking)

Tel: +44 (0) 203 829 5000

NOTES TO EDITORS

 

About Symphony Environmental

 

 

Symphony's d2w masterbatch technology is added to polyethylene (PE) and polypropylene (PP) products at the manufacturing stage at little or no extra cost, and ensures that if they get into the environment at the end of their useful life they will not create microplastics and lie or float around for decades. Instead they will safely biodegrade, leaving no microplastics or toxicity. If they get collected during their useful life they can be recycled with ordinary PE and PP without separation See https://www.biodeg.org/subjects-of-interest/recycling-2/

 

Symphony also supplies a range of plastic technologies under its d2p (designed to protect) brand www.d2p.net to provide protection against insects, viruses, bacteria, fungi, rodents, odours, and fire. It has also introduced a new product under its NbR brand https://www.symphonyenvironmental.com/natural-biodegradable-resin/ to reduce the amount of fossil-derived material in plastic products.

 

Symphony has a diverse and growing customer-base and has established itself as an international business with over 70 distributors around the world. Products made with Symphony's plastic technologies are now available in nearly 100 countries and in many different product applications. Symphony itself is certified according to ISO9001 and ISO14001.

 

Symphony actively participates in the Committee work of the British Standards Institute (BSI), the American Standards Organisation (ASTM), the European Standards Organisation (CEN), and the International Standards Organisation (ISO).

 

Further information on the Group can be found at www.symphonyenvironmental.com and twitter @SymphonyEnv

 

See also Symphony on Instagram and Linkedin.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGPUPABUPAGAB
Date   Source Headline
12th Oct 20187:00 amRNSTrading Statement
25th Sep 20187:07 amRNSNew distributor launch held in Jordan
30th Aug 20187:00 amRNSInterim Results
6th Aug 20187:00 amRNSTrading & Operations Update
23rd Jul 20188:09 amRNSOxo-biodegradable technology statement
20th Jul 20181:10 pmRNSResponse to BBC Coverage
20th Jul 20189:05 amRNSSecond Price Monitoring Extn
20th Jul 20189:00 amRNSPrice Monitoring Extension
29th May 201812:51 pmRNSDirector/PDMR Shareholding
21st May 20181:01 pmRNSExercise of Warrants and Director Dealing
15th May 20184:40 pmRNSSecond Price Monitoring Extn
15th May 20184:35 pmRNSPrice Monitoring Extension
15th May 201812:02 pmRNSResult of AGM
15th May 20187:01 amRNSAGM Statement
15th May 20187:00 amRNSTrading and Operations Update
3rd May 20187:00 amRNSNew Product Launches
1st May 20187:00 amRNSCollaboration Agreement and Strategic Investment
20th Apr 20187:00 amRNSSymphony Director on Sky News
19th Apr 20187:00 amRNSPosting of Accounts and Notice of AGM
18th Apr 20187:00 amRNSResults of YouGov survey
10th Apr 20187:00 amRNSOxo-biodegradable plastic legislation
9th Apr 20188:10 amRNSRemarks Delivered at 2018 ECOSOC Partnership Forum
6th Apr 20187:00 amRNSDirectorate Change
22nd Mar 201810:35 amRNSDirector Shareholding
14th Mar 20187:00 amRNSPreliminary Results
13th Mar 20183:57 pmRNSExercise of Options & Issue of New Ordinary Shares
2nd Mar 20187:00 amRNSExercise of Options
30th Jan 20187:00 amRNSIntroduction to d2w on the BBC World Service
12th Jan 201810:14 amRNSInterview on Sky News
8th Jan 20182:43 pmRNSDirector/PDMR Shareholding
4th Jan 20184:15 pmRNSExercise of Options
4th Jan 20184:09 pmRNSExercise of Options & Issue of New Ordinary
4th Jan 20187:00 amRNSTrading Update
15th Dec 20177:00 amRNSCourt Approval of Capital Reduction
30th Nov 20177:00 amRNSCapital Reduction Effective Date
8th Nov 201712:26 pmRNSResult of EGM
7th Nov 20171:57 pmRNSNotification of Major Holdings
27th Oct 20177:00 amRNSTrading Update
19th Oct 20177:00 amRNSProposed Capital Reduction & Notice of EGM
29th Sep 20177:00 amRNSHolding(s) in Company
7th Sep 20177:00 amRNSInterim Results
11th Jul 20173:49 pmRNSHolding(s) in Company
31st May 20177:00 amRNSDirector/PDMR Shareholding
22nd May 20172:34 pmRNSDirector/PDMR Shareholding
12th May 201710:54 amRNSResult of AGM
12th May 20177:00 amRNSAGM Statement
9th May 20174:34 pmRNSExercise of Options
9th May 201710:47 amRNSExercise of Options
4th May 201711:25 amRNSDirector/PDMR Shareholding
3rd May 201711:29 amRNSExercise of Options and Director Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.